CSIMarket


Celgene Corp  (CELG)
Other Ticker:  
 

Celgene Corp

CELG's Fundamental analysis








Looking into Celgene growth rates, revenue grew by 16.14 % in III. Quarter 2019 from the same quarter a year ago. Ranking at No. 996

Major Pharmaceutical Preparations industry recorded growth of revenues by 4.22 %

Celgene's net income grew by 56.28 % in III. Quarter 2019 year on year, above company average,

More on CELG's Growth


Celgene
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Celgene PEG ratio is at 0.13 Company is currently trading with Price to Cash flow multiple of 11.08 in trailing twelve-month period.
Company
13.33
PE TTM   
Industry
2027.12
PE TTM    
Company's Price to Sales ratio is at 4.65.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.81.


More on CELG's Valuation
 
 Total Debt (Millions $) 19,787
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 2,824,684
 Net Income/Employee (TTM) $ 305,057
 Receivable Turnover (TTM) 7.37
 Tangible Book Value (Per Share $) -16.86

Celgene
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Celgene PEG ratio is at 0.13 Company is currently trading with Price to Cash flow multiple of 11.08 in trailing twelve-month period.
Company
13.33
PE TTM   
Industry
2027.12
PE TTM    
Company's Price to Sales ratio is at 4.65.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.81.

Celgene Price to Book Ratio is at 6.53 lower than Indusry Avg. of 1298.49. and higher than S&P 500 Avg. of -1999.75

More on CELG's Valuation

  Market Capitalization (Millions $) 78,961
  Shares Outstanding (Millions) 730
  Employees 6,012
  Revenues (TTM) (Millions $) 16,982
  Net Income (TTM) (Millions $) 1,834
  Cash Flow (TTM) (Millions $) 7,124
  Capital Exp. (TTM) (Millions $) -695
  Total Debt (Millions $) 19,787
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 2,824,684
  Net Income/Employee(TTM) $ 305,057
  Receivable Turnover Ratio (TTM) 7.37
  Tangible Book Value (Per Share $) -16.86

  Market Capitalization (Millions $) 78,961
  Shares Outstanding (Millions) 730
  Employees 6,012
  Revenues (TTM) (Millions $) 16,982
  Net Income (TTM) (Millions $) 1,834
  Cash Flow (TTM) (Millions $) 7,124
  Capital Exp. (TTM) (Millions $) -695


    CELG's Profitability Comparisons
Celgene achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2019 to 50.09 % from 47.98 % in II. Quarter.

Celgene net profit margin of 37.41 % is currently ranking no. 17 in Major Pharmaceutical Preparations industry, ranking no. 25 in Healthcare sector and number 319 in S&P 500.


Profitability by Segment



  Ratio
   Capital Ratio (MRQ) 2.89
  Total Debt to Equity (MRQ) 1.64
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.44
  Inventory Turnover Ratio (TTM) 1.68



Celgene achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2019 to 50.09 % from 47.98 % in II. Quarter.

Celgene net profit margin of 37.41 % is currently ranking no. 17 in Major Pharmaceutical Preparations industry, ranking no. 25 in Healthcare sector and number 319 in S&P 500.

More on CELG's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com